Intraspinal Cord Tumor - Symptoms, Causes, Treatment & Prevention

Overview

Intraspinal cord tumors are abnormal growths that arise within the spinal canal, either inside the spinal cord (intramedullary) or in the surrounding meninges and nerve roots (extramedullary). Although they represent a small fraction of all central‑nervous‑system neoplasms, they can cause significant neurological disability because of the limited space within the vertebral column.

• Incidence: Approximately 2–5 cases per 100,000 people each year in the United States, representing < 1 % of all cancers.¹
• Age distribution:
  • Intramedullary tumors (e.g., astrocytoma, ependymoma) are most common in children and young adults.
  • Extramedullary tumors (e.g., meningioma, schwannoma) peak in middle‑aged to older adults, especially women for meningioma.
• Gender: Slight female predominance for meningiomas; male predominance for spinal schwannomas is modest.

Symptoms

Symptoms reflect the tumor’s location (intramedullary vs. extramedullary), size, and growth rate. They often develop gradually, but rapid worsening can occur if the tumor bleeds or compresses the cord acutely.

General Neurological Signs

• Pain: Persistent back or neck pain that may radiate along a nerve root (radiculopathy) or be diffuse.
• Motor weakness: Progressive loss of strength in the arms or legs, sometimes asymmetric.
• Sensory changes: Numbness, tingling, or “pins‑and‑needles” sensations below the level of the lesion.
• Gait disturbance: Unsteady walking, difficulty with balance, or a tendency to fall.
• Spasticity: Increased muscle tone and reflexes (hyperreflexia) below the tumor.

Specific Manifestations by Tumor Location

• Cervical spine: Weakness in the hands, fine‑motor difficulty, neck pain, and possible respiratory compromise if high cervical levels are involved.
• Thoracic spine: Mid‑back pain, weakness or paralysis of the legs, bowel/bladder dysfunction.
• Lumbar spine: Lower‑back pain, sciatica‑like leg pain, loss of ankle reflexes.
• Intramedullary tumors: Bilateral symptoms, early loss of sensation, and a characteristic “syrinx” (fluid‑filled cavity) may develop.
• Extramedullary tumors: Often cause unilateral radicular pain before motor deficits appear.

Autonomic & Constitutional Symptoms

• Urinary urgency, frequency, or retention.
• Constipation or loss of bowel control.
• Fatigue and unexplained weight loss (more common with malignant lesions).

Causes and Risk Factors

Most intraspinal tumors are primary (originating in spinal tissues). A minority are metastatic deposits from cancers elsewhere (breast, lung, prostate).

Known Causes

• Genetic syndromes:
  • Neurofibromatosis type 1 (NF1) – increases risk for schwannomas and neurofibromas.
  • Neurofibromatosis type 2 (NF2) – predisposes to bilateral vestibular schwannomas and spinal schwannomas.
  • Von Hippel‑Lindau disease – associated with hemangioblastomas.
• Previous radiation therapy: Childhood cranial or spinal radiation raises risk of later spinal cord tumors.
• Congenital malformations: E.g., tethered cord syndrome can predispose to tumor formation.

Risk Factors

• Age – certain subtypes have characteristic age peaks.
• Family history of the above genetic syndromes.
• Prior exposure to therapeutic radiation.
• Male sex for schwannomas (slight increase), female sex for meningiomas.

Diagnosis

Early recognition relies on a high index of suspicion and prompt imaging.

Clinical Evaluation

• Comprehensive neurological exam (strength, sensation, reflexes, gait).
• Medical history focused on onset, progression, and any prior cancers or radiation.

Imaging Studies

• MRI (Magnetic Resonance Imaging): The gold‑standard. Provides detailed soft‑tissue contrast; gadolinium contrast helps delineate tumor margins and differentiate tumor from cyst.²
• CT (Computed Tomography): Useful when MRI is contraindicated (e.g., pacemaker) or to evaluate bony involvement.
• Myelography: Rarely used now, but can outline blockages in the cerebrospinal fluid (CSF) flow.

Additional Diagnostic Tools

• Neurological electrophysiology: Somatosensory evoked potentials (SSEPs) may detect functional impairment.
• Biopsy: Usually performed intra‑operatively; histopathology determines tumor type and grade (WHO classification).
• CSF analysis: May aid in diagnosing certain malignant or infectious processes.

Treatment Options

Management is individualized based on tumor type (benign vs. malignant), size, location, patient age, and neurologic status.

Surgical Intervention

• Goal: Maximal safe resection while preserving neurologic function.
• Techniques include laminectomy, laminoplasty, and microsurgical tumor excision.
• Intra‑operative neuro‑monitoring (MEPs & SSEPs) reduces risk of postoperative deficits.

Radiation Therapy

• External beam radiation (EBRT): Standard for residual or recurrent disease.
• Stereotactic radiosurgery (SRS): Precise, high‑dose treatment useful for small, well‑defined lesions (e.g., schwannoma, meningioma).
• Proton therapy may limit dose to surrounding tissue, especially in pediatric patients.

Chemotherapy & Targeted Therapy

• Primarily for high‑grade malignant tumors (e.g., glioblastoma, metastatic disease).
• Agents such as temozolomide, carboplatin, or newer targeted inhibitors (e.g., bevacizumab for VEGF‑driven tumors) are used per oncologic protocols.

Adjunctive & Supportive Measures

• Steroids (e.g., dexamethasone): Reduce peritumoral edema and improve symptoms while awaiting definitive treatment.
• Pain management: NSAIDs, neuropathic agents (gabapentin, duloxetine), or opioid analgesics as needed.
• Physical & occupational therapy: Essential for maintaining mobility and independence.
• Bladder/bowel programs: Catheterization schedules, bowel regimens, or sacral nerve stimulation.

Living with an Intraspinal Cord Tumor

Long‑term care focuses on functional preservation, symptom control, and psychosocial wellbeing.

Daily Management Tips

• Activity modification: Avoid heavy lifting or high‑impact sports that could exacerbate spinal stress.
• Posture & ergonomics: Use supportive chairs, adjustable workstations, and lumbar rolls to reduce strain.
• Regular exercise: Low‑impact activities (swimming, stationary bike, gentle yoga) improve strength and circulation.
• Skin care: For patients with reduced sensation, inspect skin daily to prevent pressure sores.
• Medication adherence: Keep a medication list; use pill organizers or reminder apps.
• Follow‑up schedule: MRI every 6–12 months for benign tumors after resection; more frequent for malignant lesions.
• Support networks: Connect with spinal tumor support groups, counseling services, and rehabilitation specialists.

Rehabilitation Strategies

• Strength training targeting unaffected muscle groups.
• Balance training and gait re‑education with a physical therapist.
• Assistive devices (canes, walkers, ankle‑foot orthoses) as needed.
• Pelvic floor therapy for bladder dysfunction.

Prevention

Because most spinal cord tumors are not preventable, emphasis is placed on reducing modifiable risk factors and early detection.

• Avoid unnecessary radiation: Discuss alternatives with physicians if frequent imaging is required.
• Genetic counseling: Families with NF1, NF2, VHL, or other hereditary syndromes should pursue counseling and periodic screening.
• Healthy lifestyle: While it does not eliminate risk, maintaining overall health supports immune function and recovery.
• Prompt evaluation of new neurologic symptoms: Early imaging can catch tumors before irreversible damage occurs.

Complications

If left untreated or inadequately managed, intraspinal cord tumors can lead to serious sequelae.

• Progressive neurological deficit: Permanent paralysis, loss of sensation, or chronic pain.
• Bladder and bowel dysfunction: May require long‑term catheterization or colostomy.
• Spinal instability: Surgical removal of bone can necessitate fusion procedures.
• Secondary scoliosis: Particularly in children with growing spines.
• Hydrocephalus: Rare, but obstructive CSF flow from large intramedullary lesions can occur.
• Malignant transformation: Low‑grade tumors can become higher‑grade over time.

When to Seek Emergency Care

---

**References**

1. Centers for Disease Control and Prevention. Cancer Incidence Estimates. Accessed May 2024.
2. Mayo Clinic. Spinal Cord Tumor Diagnosis and Treatment. Updated 2023.
3. National Institute of Neurological Disorders and Stroke. Spinal Cord Tumor Fact Sheet. 2022.
4. World Health Organization. Cancer Fact Sheet. 2023.
5. Cleveland Clinic. Spinal Cord Tumor Overview. Reviewed 2024.